Sharps Technology Inc (STSS) News

Took flip… no longer in…🥳

getting crushed by exercised warrants, dilution and looks like an rs coming up in March...

$STSS GET YOUR CHEAP SHARES BEFORE THE EXPLOSION STARTS THIS WEEK

13G out end of the day Friday. Buyer almost loaded 2mil shares. Same one as HEPA.

 $STSS if MM let her run we should see her at dollar land by Next week 

$STSS Oversold rebound play... Offering closed and heavily shorted. Looking for a squeeze on this one. CTB 80.45% and Zero shares to borrow. Plan is to hold overnight. Think we see a nice rebound next week.

$STSS Dollar land by Next week

Nice move off of lows

STSS...42s hitting here...🥳

georgie18

Member Level
Re: georgie18 post# 389415

Thursday, January 30, 2025 3:40:05 PM

Post#
389419
of 389421
STSS...4054...HOD...🥳

georgie18

Member Level
Re: georgie18 post# 31215

Thursday, January 30, 2025 2:32:34 PM

Post#
31222
of 31233
STSS...3884...Red to Green Here...🥳

georgie18

Member Level
Re: georgie18 post# 389302

Thursday, January 30, 2025 1:53:35 PM

Post#
389410
of 389414
STSS...3714...Trying Red to Green here off that .33 range dip...🥳

$STSS AH looking good and why shouldn’t be, stock is extremely over sold RSI at 12 with $20 Million in the bank and a New $200 Million contract I say dollar land by Next week now chasers going to chase it.

STSS...4054...HOD...🥳

georgie18

Member Level
Re: georgie18 post# 31215

Thursday, January 30, 2025 2:32:34 PM

Post#
31222
of 31233
STSS...3884...Red to Green Here...🥳

georgie18

Member Level
Re: georgie18 post# 389302

Thursday, January 30, 2025 1:53:35 PM

Post#
389410
of 389414
STSS...3714...Trying Red to Green here off that .33 range dip...🥳

$STSS - extremely over sold RSI at 12 with $20 Million in the bank and a New $200 Million contract Gap To Fill at $1.40 

STSS...3884...Red to Green Here...🥳

georgie18

Member Level
Re: georgie18 post# 389302

Thursday, January 30, 2025 1:53:35 PM

Post#
389410
of 389414
STSS...3714...Trying Red to Green here off that .33 range dip...🥳

STSS...3714...Trying Red to Green here off that .33 range dip...🥳

STSS....40...🥳...https://www.globenewswire.com/news-release/2025/01/29/3017378/0/en/Sharps-Technology-Inc-Announces-Closing-of-Upsized-20-0-Million-Underwritten-Public-Offering.html

$STSS Sharps Technology’s SC Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.


Sharps is negotiating additional pharma-segment purchase commitments for orders over the next three years, with shipments expected to begin by Q2 of 2025.



https://finance.yahoo.com/news/sharps-technology-sc-asset-purchase-123000998.html

STSS, new 52 week low

Don't know but averaged down to .39 sold 80% just now at .44 hold a few free shares now 

It's just an unbelievably dramatic overreaction to 20 million in PP. Why?

Offering at $1.40 just grabbed some .40s on beat down in Chinatown 

I would think a great demand on their products would result in big uptick in STSS price. Demand that wipes out the inventory is rather rare in my thinking! Thoughts? In at $ 1.80 ,$1.84, and $ 1.91

Sells out inventory. Hmmmmmmmm: Sharps Technology Signs Sales Agreements to Support Major European Healthcare Network and Sells Out Its Inventory for SecureGard
Signed multiple agreements to sell its SecureGard syringe inventory, with initial shipments and revenue commencing in early December
Agreements also include new forecasted orders and commitments for all current SecureGard capacity, to begin in Q2 2025
The SecureGard agreements will strengthen the potential revenue curve for the Hungary Operation starting in 2024
NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, has begun deliveries of its 1mL and 3mL SecureGard safety syringes under the new sales agreements with a prominent European medical supply company serving Poland, Slovakia, and the Czech Republic. To meet demand in the region, Sharps’ customer has requested additional deliveries by year-end 2024 and committed to purchasing all available plant inventory by Q1 2025.

As a supplier to the largest network of hospitals and outpatient clinics in Central and Eastern Europe, the customer plans to purchase Sharps’ entire existing inventory of 1mL and 3mL SecureGard inventory warehoused in Hungary. This would be followed by new production orders starting in Q2 2025. These orders will consume all currently available SecureGard production capacity of 35 million units at the Hungary manufacturing facility. The customer has also expressed interest in Sharps’ U.S. inventory to fulfill a need for safety syringe supplies in Northern Africa.

The demand for Sharps’ innovative injection solutions continues to grow rapidly, with injectables remaining the preferred delivery method for therapies such as vaccines, biologics, weight loss and maintenance, ophthalmic and cosmetic applications, gene therapies, and diabetes and inflammatory disease management. With increasing levels of interest and potential demand for the Company’s high-quality smart safety syringe products in the region, Sharps is collaborating with both government and private investment sources in Hungary to expand the current manufacturing footprint and take advantage of the need to increase both SecureGard and SoloGard manufacturing capacity. The expansion will be planned to increase the annual SecureGard capacity to more than 100 million units, and the SoloGard capacity to more than 125 million units.

Sharps’ SecureGard and SoloGard product lines focus on low waste and ultra-low waste syringe technologies that also incorporate active safety features to fill the healthcare industry’s demand for the highest quality drug delivery solutions.

All inventory sold$$$$ 🚀🚀🚀🚀can we see $2.89- 3.85 profit zone 

Stick those needles up $2.73 + 40%! 2m floater

STSS new 52 week low

STSS anew 52=week low

Until when did the Nasdaq 180 day exemption give them? R/S could happen ...

STSS..........................................https://stockcharts.com/h-sc/ui?s=STSS&p=W&b=5&g=0&id=p86431144783

What's that?

Game! Blouses!

Just loud pipe down

my fist

no but i hate idiots with a big mouth

Shifting here Peter uterus

Who's to and who's bottom?

Must have struck a nerve

give me 1min and you cry for your mamma idiot

Tell your husband I said hi

$$$$$ in the pocket smarty

Large Red shoes red nose

Clowns working overtime solid news and company

The orders keep coming in...Bound to go up over time.

You're ready?

Nobody

down down down

Up up up

ouch...now you know who i am...watch and learn

They're trying hard

Faces could melt imo

STSS Sharps Technology Enters Into 5-Year Sales Agreement With Strategic U.S. Medical Products Company Creating +$50M In New Revenue For EU Facility, Definitive Agreement Sells Out The 10mL SoloGard Production Capacity At Sharps' Manufacturing Site
BENZINGA
53 mins ago
Definitive agreement sells out the 10mL SoloGard production capacity at Sharps' manufacturing site in the EU and drives expansion to support the project's growth in the future

Sharps' portfolio of products provides attractive options to the U.S. Pharmaceutical Healthcare Industry as companies look for alternatives to Chinese-manufactured disposable syringes

Sharps has exceeded the product sales commitments for the EU-based facility made to investors in the June 2022 Shareholder Letter

NEW YORK, July 25, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (STSS.NaE), , an innovative medical device and pharmaceutical packaging company offering patented, best-in-class prefillable and disposable syringe products, has successfully concluded negotiations and signed a contract with a prominent U.S.-based supplier of medical saline and water products to supply them with customized 10mL SoloGard syringes manufactured at Sharps' facility in the EU. The customer initiated an evaluation of Sharps' SoloGard product in light of the recent FDA recalls and tariffs imposed on Chinese supplied syringes. Their successful evaluation of the SoloGard syringes led to the execution of a five-year sales agreement that completely sells out the currently available manufacturing capacity for the 10mL SoloGard product. This transformative syringe program will drive the need for near-term expansion to support the current customer projects slated for the Hungary plant.